Form 8-K - Current report:
SEC Accession No. 0000950170-25-085116
Filing Date
2025-06-12
Accepted
2025-06-12 07:00:25
Documents
10
Period of Report
2025-06-06
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hura-20250606.htm   iXBRL 8-K 102994
  Complete submission text file 0000950170-25-085116.txt   221334

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20250606.xsd EX-101.SCH 30874
13 EXTRACTED XBRL INSTANCE DOCUMENT hura-20250606_htm.xml XML 4712
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 251041629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)